Logo

Neurome to Acquire TOGA Gene-Expression Platform, All Other Assets from Digital Gene Technologies

Aug 11, 2004

NEW YORK, Aug. 11 (GenomeWeb News) - Neurome plans to buy "substantially all" the assets owned by Digital Gene Technologies, including its gene-expression assays and gene-expression-analysis platform called TOGA, the companies said yesterday.

 

Neurome, which develops databases that depict and integrate gene-expression patterns of the brain, will also acquire DGT's entire patent estate. This includes data and discoveries generated in commercial and academic research programs.

Terms of the acquisition were not disclosed.

 

Neurome and DGT are both based in La Jolla, Calif.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.